Literature DB >> 31686320

Regulation of glucose and lipid metabolism in health and disease.

Ligong Chen1, Xiao-Wei Chen2, Xun Huang3, Bao-Liang Song4, Yan Wang5, Yiguo Wang6.   

Abstract

Glucose and fatty acids are the major sources of energy for human body. Cholesterol, the most abundant sterol in mammals, is a key component of cell membranes although it does not generate ATP. The metabolisms of glucose, fatty acids and cholesterol are often intertwined and regulated. For example, glucose can be converted to fatty acids and cholesterol through de novo lipid biosynthesis pathways. Excessive lipids are secreted in lipoproteins or stored in lipid droplets. The metabolites of glucose and lipids are dynamically transported intercellularly and intracellularly, and then converted to other molecules in specific compartments. The disorders of glucose and lipid metabolism result in severe diseases including cardiovascular disease, diabetes and fatty liver. This review summarizes the major metabolic aspects of glucose and lipid, and their regulations in the context of physiology and diseases.

Entities:  

Keywords:  cholesterol; endoplasmic reticulum; fatty acid; glucose; lipid droplet; lysosome; metabolic disease

Mesh:

Substances:

Year:  2019        PMID: 31686320     DOI: 10.1007/s11427-019-1563-3

Source DB:  PubMed          Journal:  Sci China Life Sci        ISSN: 1674-7305            Impact factor:   6.038


  27 in total

1.  Human umbilical cord-derived mesenchymal stem cell-exosomal miR-627-5p ameliorates non-alcoholic fatty liver disease by repressing FTO expression.

Authors:  Lidan Cheng; Peng Yu; Fangfang Li; Xueling Jiang; Xiaojuan Jiao; Yunfeng Shen; Xiaoyang Lai
Journal:  Hum Cell       Date:  2021-08-19       Impact factor: 4.174

Review 2.  Mitochondrial respiratory quiescence: A new model for examining the role of mitochondrial metabolism in development.

Authors:  Helin Hocaoglu; Matthew Sieber
Journal:  Semin Cell Dev Biol       Date:  2022-04-18       Impact factor: 7.499

3.  LINE-1 promotes tumorigenicity and exacerbates tumor progression via stimulating metabolism reprogramming in non-small cell lung cancer.

Authors:  Zeguo Sun; Rui Zhang; Xiao Zhang; Yifei Sun; Pengpeng Liu; Nancy Francoeur; Lei Han; Wan Yee Lam; Zhengzi Yi; Robert Sebra; Martin Walsh; Jinpu Yu; Weijia Zhang
Journal:  Mol Cancer       Date:  2022-07-16       Impact factor: 41.444

4.  Renal UTX-PHGDH-serine axis regulates metabolic disorders in the kidney and liver.

Authors:  Hong Chen; Chong Liu; Qian Wang; Mingrui Xiong; Xia Zeng; Dong Yang; Yunhao Xie; Hua Su; Yu Zhang; Yixue Huang; Yuchen Chen; Junqiu Yue; Chengyu Liu; Shun Wang; Kun Huang; Ling Zheng
Journal:  Nat Commun       Date:  2022-07-04       Impact factor: 17.694

5.  The Role of H2S in the Metabolism of Glucose and Lipids.

Authors:  Hai-Jian Sun; Zhi-Yuan Wu; Xiao-Wei Nie; Jin-Song Bian
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

6.  Neuronal lipolysis participates in PUFA-mediated neural function and neurodegeneration.

Authors:  Leilei Yang; Jingjing Liang; Sin Man Lam; Ahmet Yavuz; Guanghou Shui; Mei Ding; Xun Huang
Journal:  EMBO Rep       Date:  2020-10-09       Impact factor: 8.807

7.  Disruption of the ERLIN-TM6SF2-APOB complex destabilizes APOB and contributes to non-alcoholic fatty liver disease.

Authors:  Bo-Tao Li; Ming Sun; Yun-Feng Li; Ju-Qiong Wang; Zi-Mu Zhou; Bao-Liang Song; Jie Luo
Journal:  PLoS Genet       Date:  2020-08-10       Impact factor: 5.917

8.  Exploring the Role of a Novel Peptide from Allomyrina dichotoma Larvae in Ameliorating Lipid Metabolism in Obesity.

Authors:  Sung Mun Bae; Meiqi Fan; Young-Jin Choi; Yujiao Tang; Gwanghui Jeong; Kyungjae Myung; Byung-Gyu Kim; Eun-Kyung Kim
Journal:  Int J Mol Sci       Date:  2020-11-12       Impact factor: 5.923

9.  TBL2 methylation is associated with hyper-low-density lipoprotein cholesterolemia: a case-control study.

Authors:  Yang Li; Shuai Liu; Yong-Tao Wang; Han Min; Dilare Adi; Xiao-Mei Li; Yi-Ning Yang; Zhen Yan Fu; Yi-Tong Ma
Journal:  Lipids Health Dis       Date:  2020-08-18       Impact factor: 3.876

Review 10.  Abnormal metabolic processes involved in the pathogenesis of non-alcoholic fatty liver disease (Review).

Authors:  Mingmei Shao; Zixiang Ye; Yanhong Qin; Tao Wu
Journal:  Exp Ther Med       Date:  2020-08-28       Impact factor: 2.447

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.